Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Assessment of a Medical Device for Tumour Cell Retention and Radiotherapy Sensitization in Patients With Suspected High-grade Glioma

NCT07725640 is registered in ClinicalTrials.gov with Batea Oncology as lead sponsor.

NCT NCT07725640
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07725640 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Assessment of a Medical Device for Tumour Cell Retention and Radiotherapy Sensitization in Patients With Suspected High-grade Glioma
Lead sponsor
Batea Oncology
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 30, 2026
Completion date
October 30, 2028
Enrollment
15 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

glioma, high-grade glioma (hgg), surgical resection